SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000921895-10-000121
Filing Date
2010-02-03
Accepted
2010-02-03 16:53:07
Documents
2

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 TO THE SCHEDULE 13G sc13ga200322met_12312009.htm SC 13G/A 237428
2 JOINT FILING AGREEMENT ex991to13ga200322met_123109.htm EX-99.1 31143
  Complete submission text file 0000921895-10-000121.txt   270485
Mailing Address 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611
Business Address 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611 3125066500
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 6282 Investment Advice

Mailing Address 9390 TOWNE CENTRE DRIVE SAN DIEGO CA 92121
Business Address 9390 TOWNE CENTRE DRIVE SAN DIEGO CA 92121 858-587-2770
METABASIS THERAPEUTICS INC (Subject) CIK: 0001053221 (see all company filings)

IRS No.: 330753322 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-80372 | Film No.: 10571289
SIC: 2834 Pharmaceutical Preparations